Olaf Klungel

Managing Uncertainties Due to Limited Evidence in Economic Evaluations of Novel Anti-Tuberculosis Regimens: A Systematic Review

Olaf Klungel, T I Armina Padmasawitri, Sarah Maria Saragih, 2019, PharmacoEconomics - Open.

Reporting to Improve Reproducibility and Facilitate Validity Assessment for Healthcare Database Studies V1.0.

Olaf Klungel, Rosa Gini, Jeffrey Brown, 2017, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Disparities in model-based cost-effectiveness analyses of tuberculosis diagnosis: A systematic review

Olaf Klungel, Bachti Alisjahbana, T I Armina Padmasawitri, 2018, PloS one.

The reporting of studies conducted using observational routinely collected health data statement for pharmacoepidemiology (RECORD-PE)

Olaf Klungel, David Moher, Katie Harron, 2018, British Medical Journal.

Reporting to Improve Reproducibility and Facilitate Validity Assessment for Healthcare Database Studies V1.0

Olaf Klungel, Rosa Gini, Liam Smeeth, 2017, Pharmacoepidemiology and drug safety.

The identification of incident cancers in UK primary care databases: a systematic review

Krishnan Bhaskaran, Olaf Klungel, Liam Smeeth, 2015, Pharmacoepidemiology and drug safety.

Using Real-World Data in Health Technology Assessment (HTA) Practice: A Comparative Study of Five HTA Agencies

Olaf Klungel, Wim Goettsch, Hans Hillege, 2017, PharmacoEconomics.

What Is Real-World Data? A Review of Definitions Based on Literature and Stakeholder Interviews.

Olaf Klungel, Wim Goettsch, Hans Hillege, 2016, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.